Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic Fibrosis

NCT01621867 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01621867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01621867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic Fibrosis
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
May 31, 2014
Enrollment
130 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis